Juan Del Valle

Juan Del Valle

Drug Discovery and Molecular Recognition

Biography

2019-present
William K. Warren Family Associate Professor, University of Notre Dame
2015-2019
Associate Professor, University of South Florida
2009-2015
Assistant Professor, University of South Florida and Moffitt Cancer Center
2006-2008
Assistant Professor, New Mexico State University
2004-2006
Postdoctoral Scholar, University of Montreal
2004
Ph.D. in Chemistry, University of California San Diego
1999
B.A. in Chemistry, Carleton College

Selected Awards

2018
Undergraduate Teaching Award, University of South Florida
2010
CIBA Young Scientist Award, ACS Younger Chemists Committee
2010
Milestone Award, Miles for Moffitt Foundation

Research Interests

The Del Valle lab is broadly interested in bringing the power of organic chemistry to bear on current challenges in drug discovery and molecular recognition. Our research program lies at the interface of organic synthesis and chemical biology, with an emphasis on the structure-based design of biologically active peptidomimetics and small molecules. Current projects are described below:

Constrained peptides targeting protein-protein interactions

Despite the importance of well-defined protein-protein interactions (PPIs) in promoting various diseases, the development of molecules capable of modulating these interactions remains a significant challenge. This situation stems from a chemical biology paradox in which the need to bind large protein surfaces with precise topology is beset by the flexibility and cell-impermeability of high molecular weight inhibitors. Our lab is targeting a number of PPIs using designed protein mimics. Efforts in this area include disruption of neurodegenerative protein aggregation as well as PPIs that drive cancer.

Non-ribosomal peptide natural products

Nature remains a prolific source of drug candidates, with almost half of all FDA-approved therapeutics classified as natural product derived or inspired. Non-ribosomal peptides (NRPs) represent a particularly promising class of natural products with diverse biological activities. NRPs are predisposed to interact with protein receptors and often feature drug-like properties not typically seen in canonical polypeptides. We are pursuing the synthesis of NRPs in which unusual amino acids or unique backbone modifications are important for biological activity. We also leverage synthetic access to unusual amino acids in order to study their effects on native peptide conformation and their utility in other drug design applications.

Modulators of ER stress response

Endoplasmic reticulum (ER) stress resulting from gene amplification and aberrant protein expression is an established hallmark of cancer. As a result, many tumors hijack ER stress response mechanisms in order to evade cell death. As part of a highly collaborative effort with immunologists, cell biologists, and clinicians, our lab has developed a series of potent inhibitors of the IRE1/XBP1 signaling arm of the ER stress response. These compounds have helped to establish the clinical relevance of targeting IRE1 in a variety of disease models including chronic lymphocytic leukemia, c-Myc-driven cancers, and graft-versus-host disease. Current efforts are aimed at chemical optimization, advanced preclinical development, and elucidating the role of ER stress response in other diseases using new chemical probes.

Recent Papers

  • Elbatrawi, Y. M., Pedretty, K. P., Giddings, N., Woodcock, H. L., Del Valle, J. R. "δ-Azaproline and Its Oxidized Variants" 2020 ACS Applied Materials and Interfaces, in press. DOI:10.1021/acs.joc.9b03384.
  • Howard, E. H., Cain, C. F., Kang, C., Del Valle, J. R. "Synthesis of Enantiopure ϵ-Oxapipecolic Acid" 2020 Journal of Organic Chemistry, 85 (3), pp. 1680-1686. DOI:10.1021/acs.joc.9b02382.
  • Tillett, K. C., Del Valle, J. R. "N -Amino peptide scanning reveals inhibitors of Aβ42 aggregation" 2020 RSC Advances, 10 (24), pp. 14331-14336. DOI:10.1039/d0ra02009e.
  • Cain, C. F., Howard, E. H., Goodwin, J. A., Del Valle, J. R. "Synthetic studies toward eleganine A" 2019 Arkivoc, 2019 (4). DOI:10.24820/ark.5550190.p010.897.
  • Liu, L., Zhao, M., Jin, X., Ney, G., Yang, K. B., Peng, F., Cao, J., Iwawaki, T., Del Valle, J., Chen, X., Li, Q. "Adaptive endoplasmic reticulum stress signalling via IRE1α–XBP1 preserves self-renewal of haematopoietic and pre-leukaemic stem cells" 2019 Nature Cell Biology, 21 (3), pp. 328-337. DOI:10.1038/s41556-019-0285-6.
  • Shao, A., Kang, C. W., Tang, C. -. A., Cain, C. F., Xu, Q., Phoumyvong, C. M., Del Valle, J. R., Hu, C. -. A. "Structural Tailoring of a Novel Fluorescent IRE-1 RNase Inhibitor to Precisely Control Its Activity" 2019 Journal of Medicinal Chemistry, 62 (11), pp. 5404-5413. DOI:10.1021/acs.jmedchem.9b00269.

Contact Information

Primary Research Areas

Research Specialties